BLFS Q2 2022 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$41M+29.9% YoY

Gross Profit

$14M35.4% margin

Operating Income

-$9M-21.5% margin

Net Income

-$73M-179.0% margin

EPS (Diluted)

$-1.72

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$470M

Total Liabilities

$58M

Stockholders' Equity

$412M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$31M	+29.9%
Gross Profit	$14M	$13M	+13.4%
Operating Income	-$9M	-$5M	-91.4%
Net Income	-$73M	$8M	-1021.2%

Revenue Segments

Rental Revenue

$9M96%

Service Revenue

$349,0004%